SDC1 and hematologic disorder: To extend the Malibu-Glo assay to other antigens for treatment of hematologic malignancies and solid tumors, we generated Malibu-Glo reagents based on scFvs targeting CD20, CD30, CD33, BCMA, CD138 and CS1.